Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 23, 2010 | December 30, 2010 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 23, 2010 · Filed December 30, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 168,071 |
Reported balance
After 2010-12-23 transaction · row 1
1 source rowRow 1 · 2010-12-23 · Gift · Disposed 1,054 · Balance 168,071 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 15,152 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,152 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 295 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 295 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife for daughter | 296 |
Reported balance
Holding disclosure · report date 2010-12-23 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 296 F2: The reporting person disclaims beneficial ownership of all securities held by his daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 28, 2010.
F2: The reporting person disclaims beneficial ownership of all securities held by his daughters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 21,281 | $33.23 | $707,197.42 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,063 | $42.73 | $88,151.99 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 Read SEC document |
| January 31, 2006 Filed Feb 2, 2006 23:34 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,063 | $40.93 | $84,435.08 |
DisclosureSEC source: 0001104659-06-005676 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008016 · a4.xml · derivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: Common shares · 63,800 shares Expires 2015-02-17 F4 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008016 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,885 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| December 27, 2004 Filed Dec 28, 2004 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,000 | $0.00 Strike: $44.72 | $0.00 |
DisclosureSEC source: 0001104659-04-041408 · a4.xml · derivative · entry 4 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,000 shares Expires 2004-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 27, 2004 Filed Dec 28, 2004 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,955 | $46.42 | $90,751.10 |
DisclosureSEC source: 0001104659-04-041408 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,585 Read SEC document |
| December 27, 2004 Filed Dec 28, 2004 22:37 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,000 | $44.72 | $89,431.40 |
DisclosureSEC source: 0001104659-04-041408 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 18,666 | $0.00 Strike: $41.69 | $0.00 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · derivative · entry 8 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,666 Underlying: Common shares · 18,666 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 21,280 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,562 Underlying: Common shares · 21,280 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,509 | $42.00 | $147,378.00 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · nonDerivative · entry 3 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,540 Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 18,666 | $41.69 | $778,185.54 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,049 Read SEC document |
| September 01, 2004 Filed Sep 2, 2004 17:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 21,280 | $33.23 | $707,164.19 |
DisclosureSEC source: 0001104659-04-026697 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 8,761 | $0.00 Strike: $41.01 | $0.00 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · derivative · entry 7 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,761 Underlying: Common shares · 8,761 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,284 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · derivative · entry 6 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 10,284 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 8,761 | $41.01 | $359,288.61 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · nonDerivative · entry 2 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,435 Read SEC document |
| August 23, 2004 Filed Aug 25, 2004 19:15 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,284 | $32.61 | $335,372.55 |
DisclosureSEC source: 0001104659-04-025573 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 15:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $41.10 | $0.00 |
DisclosureSEC source: 0001104659-04-009263 · a4.xml · derivative · entry 5 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: common shares · 25,000 shares Expires 2014-03-30 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 8,334 on 3/31/05, 8,333 on 3/31/06 and 8,333 on 3/31/07. Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 15:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-009263 · a4.xml · nonDerivative · entry 1 LIEPMANN HOLGER A · CIK 0001283517 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,912 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.